TINCR was upregulated in human gastric carcinoma [29], and TUG1 was upregulated in many cancer tissues and cells [30]; therefore, the increased expression of LUCAT1, TINCR, and TUG1 might not be specific to ACBP and ASLB treatments. Here, TINCR is linked to cancer.